Takara Bio
Takara Bio USA Developing High-Throughput Multiplex Panels in Partnership With Clinical Labs
Premium
The laboratory-developed tests can be validated and customized by customers, which the firm says engenders increased flexibility.
Takara Bio USA, BioExcel Diagnostics Partner for Infectious Disease Panels
The firms will partner to offer a range of multiplex syndromic panels to detect infectious disease pathogens and antimicrobial resistance markers.
Takara Bio Forays Into Diagnostic Space With SmartChip COVID-19 Testing
The firm's SmartChip platform consists of a high-throughput liquid dispenser and a PCR instrument and can provide more than 5,000 reactions in one run.
Takara Bio, BioSyntagma Develop High-Throughput SARS-CoV-2 Detection Method
The new method uses Takara Bio's SmartChip PCR instrument, chips, and reagents to run 5,184 reactions per chip in less than 30 minutes.